September 29, 2026

If you put together all the new chemotherapy drugs approved over a dozen years, the average overall survival benefit is only 2.1 months. Though we often hear new cancer drugs described as “game changers” or “breakthroughs,” most afford much more modest benefits. In my last blog, I quoted an editorial in the Journal of the […]